Case report: Undifferentiated (Laryngeal) carcinoma after kidney trtansplant (1965)

Status: 
Ready to upload
Record number: 
1868
MPHO Type: 
Estimated frequency: 
Laryngeal cancer is not dealt with specifically by the Council of Europe but can likely be considered similar to oropharyngeal cancer. Most recent risk assessment for oropharyngeal cancer (Council of Europe, 2022): The presence of oropharyngeal cancer is considered an unacceptable risk for organ donation. Oropharyngeal cancer in the donor history: Treated oropharyngeal cancer is considered high-risk for organ donation. Depending on initial stage, grade, therapy, and time of recurrence-free survival (> 5 years), the risk category might decrease individually.
Time to detection: 
8 months
Alerting signals, symptoms, evidence of occurrence: 
Recipient complained of muscle aches, fatigue, vague epigastric pain not responsive to antacids 210 days after kidney transplantation and initial striking recovery. Slight elevation of serum alkaline phosphatase and urea nitrogen, elevated serum creatinine, ASAT, bilirubin. Tenderness in right upper abdominal quadrant with a vague mass in that area. Considerable peripheral and presacral edema. Liver biopsy for suspected cholangiolytic hepatitis contained undifferentiated neoplasm. Recipient died shortly after this diagnosis. The donor was known to have histologically confirmed squamous cell cardinoma of sinus piriformis, well-differentiated at the time of first diagnosis 2 years before donation. Partial laryngectomy and radical neck dissection (after pre-treatment with arterial methotrexate to reduce tumor size) revealed metastatic lymphnodes. Local tumor recurrence 4 months later appeared histologically similar to the Initial tumor but was less well-differentiated. Radiation therapy followed. In the course of another 1.5 years metastases appeared in esophagus and liver. The patient passed away and became kidney donor for the critically ill recipient who was in urgent need of a transplant due to continuous decompensation with heart failure and increasing peripheral neuropathy despite dialysis, Donor autopsy confirmed metastases in trachea, esophagus, liver, lungs, spleen, multiple lymphnodes as well as the non-transplanted contralateral kidney. No residual tumor was found at the primary laryngeal site.
Demonstration of imputability or root cause: 
The only possible investigation at that time (1965) was the histologic comparison of donor and recipient tumors. Both were undifferentiated squamous cell carcinoma, no other primary was found in the autopsy of the recipient which was conclusive of donor tumor transmission.
Imputability grade: 
3 Definite/Certain/Proven
Groups audience: 
Suggest new keywords: 
Malignancy
Case report
Kidney transplant
Histologic analysis
Head and neck
Squamous cell carcinoma/larynx and hypopharynx
Suggest references: 
McIntosh DA, McPhaul JJ, Peterson EW, Harvin JS, Smith JR, Humphreys JW, Jr. Homotransplantation of a Cadaver Neoplasm and a Renal Homograft. JAMA. 1965;192:1171-3.
Note: 
Tumor not in Adverse occurrence type: please add "Head and Neck / Squamous cell carcinoma, Larynx and hypopharynx! First review completed, June 22, 2018.
Expert comments for publication: 
Historical report from the very early (experimental) era of transplant medicine (year 1965), first report of tumor transmission from donor to recipient in the literature. The authors state " Renal homotransplantation must be considered an investigative endeavor with commitment of moribund patients to a variety of unique experimental conditions". Nowadays, transplantation medicine has very well evolved to be a routine treatment for end-stage organ failures. This report has to be seen as describing the first experiences in the field and thereby confirming that known active metatstatic disease must be an absolute contraindication for organ donation.